Renographic diagnosis of renovascular hypertension with angiotensin converting enzyme inhibition and furosemide

George N. Sfakianakis, Jacques J. Bourgoignie

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Captopril renography is a powerful tool for evaluating renovascular hypertension. In this article we examine four different protocols: 99mTc-DTPA, [131I]hippuran with captopril, [131I]hippuran with enalaprilat, and 99mTc-mercaptoacetyltriglycine (MAG3). In our experience, [131I]hippuran renograms are a reliable and reproducible test in patients both with and without azotemia. Although our experience with the new 99mTc-MAG3 technique is somewhat limited, it appears that this will also be a valuable test, which additionally has several advantages over hippuran, namely, a smaller turnaround time between test and baseline study, a smaller dose of radioactivity, better images, and more accurate counts. We look forward to the future development of this technique.

Original languageEnglish (US)
Pages (from-to)706S-710S
JournalAmerican journal of hypertension
Volume4
Issue number12
DOIs
StatePublished - Dec 1991

Keywords

  • Captopril
  • Enalaprilat
  • Hippuran
  • Mercaptoacetyltriglycine
  • Radiopharma­ceuticals
  • Renography

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Renographic diagnosis of renovascular hypertension with angiotensin converting enzyme inhibition and furosemide'. Together they form a unique fingerprint.

Cite this